Studying visceral leishmaniasis that returns in people living with HIV
Studies why this parasite disease returns in adults with HIV and improves their follow-up.
Plain-language title generated from the registry record
Registry title: Recurrent Visceral Leishmaniasis in HIV Co-Infection
Key facts
- Where
- Gonder, EthiopiaSee the site
Where in Ethiopia
- University of GondarGonder, EthiopiaTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Institute of Tropical Medicine, Belgium
- Trial code
- NCT07487350
- Record updated
- 23 March 2026
- Original description
The aim is (1) to better understand the underlying causes and predispositions for relapse and parasite persistence in visceral leishmaniasis (VL) patients living with HIV and (2) to improve treatment monitoring of this target group in EthiopiaRead full original descriptionShow less
New And Recurrent Visceral Leishmaniasis in HIV Co-Infected Ethiopian Patients: a Cohort Study
The aim is (1) to better understand the underlying causes and predispositions for relapse and parasite persistence in visceral leishmaniasis (VL) patients living with HIV and (2) to improve treatment monitoring of this target group in Ethiopia
Inclusion: VL-HIV infection 1.1. VL: microscopically confirmed parasite presence in spleen or bone marrow tissue at first episode or relapse; for known active chronic cases: decision to treat VL 1.2. HIV: confirmed viral infection (new or past); ≥18 years.
Exclusion: Not willing to provide written informed consent; Not willing to adhere to the follow-up visits; Mentally or physically incapable to participate in the study (to the discretion of the treating physician).